AFC Gamma, Inc. appointed Daniel Neville as new CEO

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers. Compensatory Arrangements of Certain Officers.


Transition of Leonard M. Tannenbaum to Executive Chairman and Chief Investment Officer


On October 26, 2023, Leonard M. Tannenbaum notified AFC Gamma, Inc. (the "Company") of his decision to resign as Chief Executive Officer of the Company, effective November 13, 2023. On October 26, 2023, Mr. Tannenbaum was appointed by the Board of Directors (the "Board") of the Company as the Executive Chairman of the Board and the Company's Chief Investment Officer.


Appointment of Daniel Neville as Chief Executive Officer


On October 26, 2023, the Board appointed Daniel Neville as the Chief Executive Officer of the Company and a member of its Investment Committee, effective as of November 13, 2023. Mr. Neville, age 37, previously served as Chief Financial Officer of Ascend Wellness Holdings, Inc. ("Ascend") beginning in August 2020 and Senior Vice President of Finance from March 2019 through August 2020. Mr. Neville has resigned from his position at Ascend, effective November 2023. Prior to his roles at Ascend, Mr. Neville served as a Managing Director at SLS Capital from January 2015 to March 2019 and as an Analyst from April 2010 to January 2015. Prior to his roles at SLS Capital, Mr. Neville worked as an investment banker at Credit Suisse in the Technology Group. Mr. Neville received a Bachelor of Science in Economics from Duke University.


Mr. Neville is party to an employment agreement with AFC Management, LLC (the "Manager"), dated October 30, 2023 (the "Employment Agreement"), which includes a one-year term that will automatically renew and be automatically extended for additional one-year terms on each subsequent anniversary of November 13, 2024, unless either the Manager or Mr. Neville provides written notice at least thirty (30) days prior to the expiration date. The Employment Agreement provides that Mr. Neville will receive an annual base salary of $625,000. Mr. Neville will also be eligible to receive annual incentive bonuses, with a maximum bonus for fiscal year 2024 equal to $400,000 (with a target bonus equal to $300,000). The Employment Agreement also provides that Mr. Neville, subject to the approval of the Board's Compensation Committee, is eligible to receive equity grants under the AFCG Stock Incentive Plan (the "Plan"), under which he will be awarded (i) in connection with his 2024 compensation (the "Sign-On Grant"), an equity grant of restricted common stock, anticipated in December 2024, having a fair value of $750,000 under the terms of the Plan and (ii) in connection with his 2025 compensation an equity grant of restricted common stock, anticipated in January 2025, having a fair value of up to $400,000 (with a target value of $300,000) under the terms of the Plan (the "2025 Grant"). The Sign-On Grant and the 2025 Grant will each vest on the following schedule: one-third (1/3rd) of such grant shall vest on each of the first (1st), second (2nd) and third (3rd) anniversary of the grant date. Mr. Neville will also be granted a membership interest in the Manager equal to twenty percent (20%) of the increase of the Company's Adjusted Capital (as such term is defined in the Company's management agreement with the Manager) from its Adjusted Capital as of September 30, 2023 for such time that Mr. Neville serves as Chief Executive Officer of the Company. The Employment Agreement also provides Mr. Neville eighteen (18) vacation days per year and eligibility to participate in the Manager's benefit plans and programs, and fringe benefit plans and programs, made available by the Manager to its executives generally, as such plans or programs may be in effect from time to time.


The Employment Agreement generally provides that, in the event of a termination of Mr. Neville's employment by the Manager without "cause" (other than due to Mr. Neville's death or "disability"), or his resignation for "good reason" (which includes a non-renewal of the Employment Agreement term by the Manager), Mr. Neville will be entitled to: (i) three months of base salary continuation; (ii) subject to Mr. Neville's timely election of continuation coverage under COBRA, payment of 100% of medical, dental and vision premiums for Mr. Neville and his dependents for three months following the month in which the termination occurs; and (iii) the Company's repurchase right with respect to Mr. Neville's ownership of the Manager shall terminate and Mr. Neville's Sign-On Grant shall fully vest.


1


The foregoing description of the Employment Agreement is qualified in its entirety by reference to the complete text of the Employment Agreement, a copy of which is filed as Exhibit 10.1 with this Form 8-K and incorporated by reference into this Item 5.02.


In addition to the compensation that Mr. Neville receives under the Employment Agreement, the Company has entered into its standard indemnification agreement with Mr. Neville, the form of which was previously filed by the Company as Exhibit 10.2 to the Registration Statement on Form S-11 (File No. 333-251762) initially filed by the Company with the Securities and Exchange Commission on January 22, 2021.


There are no arrangements or understandings between Mr. Neville and any other person pursuant to which Mr. Neville was appointed as Chief Executive Officer and there are no family relationships between Mr. Neville and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.


2